Maternal and neonatal outcomes of vitamin D supplementation in hypovitaminosis D pregnancy: preg-D randomized trial
The Journal of Clinical Endocrinology & Metabolism · 16.07.2026
DOI: 10.1210/clinem/dgag245 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 16.07.2026. Verfasst von Marlene Chakhtoura und 18 weiteren Autor:innen. Beteiligte Einrichtung: Calcium Metabolism and Osteoporosis Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut 6044/C8, Lebanon. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: American University of Beirut, Lebanon, WHO, EMRO.
Abstract (Originalsprache)
Context
Hypovitaminosis D during pregnancy is common and may have adverse maternal and neonatal effects. While randomized trials show that supplementation improves biochemical vitamin D status, the optimal dose and its effects on neonatal bone outcomes remain uncertain.
Objective
To compare the effects of 2 vitamin D supplementation doses during pregnancy on maternal and neonatal serum 25-hydroxyvitamin D (25(OH)D) at delivery, and on neonatal bone mineral content.
Methods
In this double-blind trial, pregnant women ≤17.5 weeks' gestation with baseline 25(OH)D 10 to 30 ng/mL were randomized to receive either 20 000 IU/week or 10 000 IU every 2 weeks (equivalent to 714 IU/day) vitamin D3. Primary outcomes were the proportion of women achieving a 25(OH)D level ≥20 ng/mL at delivery and neonatal bone mineral content (BMC) at ∼1 month of age. We used liquid chromatography tandem mass spectrometry (standard LC–MS/MS) at a CDC-certified laboratory.
Results
One hundred and ninety-two maternal neonatal pairs had complete biochemical data and 67 neonates had evaluable DXA scans. A significantly higher proportion (100%) of women and neonates (77%) in the higher dose group achieved 25(OH)D levels ≥20 ng/mL at delivery, compared with the lower dose group (85% and 40%, respectively, P = .001). Mean 25(OH)D in mothers and neonates at delivery followed a similar pattern (P = .001). However, neonatal subtotal whole-body BMC did not differ between groups (45.9 ± 8.5 vs 42.2 ± 7.1 g, respectively; P = .059), nor did neonatal bone mineral density or bone area. We did not identify any safety concerns related to supplementation.
Conclusion
Higher dose vitamin D supplementation safely achieved biochemical sufficiency in mothers and neonates without measurable effect on neonatal bone outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Calcium Metabolism and Osteoporosis Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut 6044/C8, Lebanon.
- Department of Obstetrics and Gynecology, American University of Beirut Medical Center, Beirut 6044/C8, Lebanon.
- Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut 6044/C8, Lebanon.
- Division of Medical Education, Weill Cornell Medicine-Qatar, Doha 24144, Qatar.
- Department of Obstetrics and Gynecology, Bahman Hospital, Haret Hreik 2828, Beirut, Lebanon.
- Department of Pediatrics, Bahman Hospital, Haret Hreik 2828, Beirut, Lebanon.
ORCID-Profile: Marlene Chakhtoura, Maya Rahme, Lama Charafeddine, Cyrus Cooper, Nicholas Harvey, Ghada El-Hajj Fuleihan
Förderung
- American University of Beirut, Lebanon
- WHO
- EMRO
- EMRPPH
- Scholars in HeAlth Research (SHARP)
- NIH HHS
- UK Medical Research Council
- NIHR Southampton Biomedical Research Centre
Zitieren
APA
Chakhtoura, M., Nassar, A. H., Ajjour, S., Rahme, M., Assaad, M., Nabulsi, M., Charafeddine, L., Mahfoud, Z. R., Tfaily, N., Diab, T., Al-Tayeh, R., Zeitoun, A., Shepherd, J. A., Cavalier, E., Cooper, C., Harvey, N., Eid, J., Chlela, M., & El-Hajj Fuleihan, G. (2026). Maternal and neonatal outcomes of vitamin D supplementation in hypovitaminosis D pregnancy: preg-D randomized trial. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag245
Vancouver
Chakhtoura M, Nassar AH, Ajjour S, Rahme M, Assaad M, Nabulsi M, et al. Maternal and neonatal outcomes of vitamin D supplementation in hypovitaminosis D pregnancy: preg-D randomized trial. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag245
BibTeX
@article{Chakhtoura2026,
author = {Chakhtoura, Marlene and Nassar, Anwar H and Ajjour, Sara and Rahme, Maya and Assaad, Mariam and Nabulsi, Mona and Charafeddine, Lama and Mahfoud, Ziyad R and Tfaily, Nawal and Diab, Taghrid and Al-Tayeh, Rihab and Zeitoun, Ali and Shepherd, John A and Cavalier, Etienne and Cooper, Cyrus and Harvey, Nicholas and Eid, Joe and Chlela, Myriam and El-Hajj Fuleihan, Ghada},
title = {Maternal and neonatal outcomes of vitamin D supplementation in hypovitaminosis D pregnancy: preg-D randomized trial},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgag245}
}
EUVIMED